WaferGen Closes $7.2M Direct Offering to Bolster Cash Position, Support SmartChip Launch

The money will help Wafergen commercially launch its high-throughput PCR system "imminently," according to a company official; and bolster the company's dwindling cash reserves in the interim.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.